The appearance and quick spread of the new severe acute respiratory syndrome
coronavirus disease, COVID-19, brought major societal challenges. Importantly, suitable …

The novel coronavirus, SARS-CoV-2, rapidly spread worldwide, causing an ongoing global
pandemic. While the respiratory system is the most common site of infection, a significant …

Background and aims The main causes of death in patients with severe Coronavirus
disease-2019 (COVID-19) are acute respiratory distress syndrome (ARDS) and multiorgan …

Increasing evidence suggests that dysregulated immune responses are associated with the
clinical outcome of coronavirus disease 2019 (COVID-19). Nucleocapsid protein (NP) …

SARS-CoV-2 diagnostic practices broadly involve either quantitative polymerase chain
reaction (qPCR)-based nucleic amplification of viral sequences or antigen-based tests such …

Background Global healthcare systems continue to be challenged by the COVID-19
pandemic, and there is a need for clinical assays that can help optimise resource allocation …

Many current treatment options for lung inflammation and thrombosis come with unwanted
side effects. The natural omega-3 fatty acids (O3FA) are generally anti-inflammatory and …

Introduction In coronavirus disease (COVID-19), inflammation takes center stage, with a
cascade of cytokines released, contributing to both inflammation and lung damage. The …

Background and aims MicroRNAs (miRNAs) and long noncoding RNAs (lncRNAs) are well‐
known types of noncoding RNAs (ncRNAs), which have been known as the key regulators of …

Ozone therapy (OT), a medical procedure, has been showing good results during the
coronavirus disease (COVID-19). We aimed to build an evidence and gaps map (EGM) of …